Though the number of approved controlled-release powder formats is modest, a rising number of pharmaceutical companies and manufacturing organisations are incorporating controlled-release powder manufacturing to their portfolios to address the growing dosage form problem for paediatric and geriatric patients. Cory Berkland, PhD, and Nathan Dormer, PhD, from Orbis Biosciences look at what this delivery system can offer.
Expert View: The Emergence of Controlled-Release Powders for Oral Administration